Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years.
- People who have been diagnosed with a specific type of stomach cancer called gastric adenocarcinoma, confirmed by a tissue sample taken during a camera examination of the stomach.
- People whose stomach cancer has been assessed as surgically removable.
- People who are generally able to carry out daily activities with no or minimal limitations (as measured by a standard medical scale called ECOG 0–1).
- People whose blood test results meet specific requirements for white blood cells, neutrophils (infection-fighting cells), haemoglobin (iron-carrying cells), and platelets (clotting cells).
- People whose heart is pumping blood effectively, with a pumping strength measurement above 50%.
- People whose liver function blood test results are within an acceptable range (confirm with trial site for exact values).
- People whose kidney function blood test results are within an acceptable range (confirm with trial site for exact values).
- People who are willing and able to follow the trial requirements for its full duration.
- People who provide written agreement to take part in the study.
- People who do not have the potential to father or carry a child in the six months before joining the trial.
Who may not be able to join:
- People who have had another type of cancer in the past five years, except for certain types of skin cancer (basal cell or squamous cell carcinoma) that have been fully treated and cured.
- People who have had a known allergic reaction to chemotherapy medicines, or for whom chemotherapy is otherwise medically unsuitable.
- People who have a serious illness or other health condition that the trial doctors determine makes participation unsafe, including poor organ function.
- People with diabetes that is not well controlled, or whose blood sugar level on the day of testing is at or above 11 mmol/L.
- People experiencing severe mental health symptoms, a reduced level of consciousness, or who are unable to complete the required assessments.
- People who are pregnant, possibly pregnant, or currently breastfeeding.
- People who are unlikely to be able to follow the trial requirements as assessed by the trial team.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenggang Zhu, Ruijin Hospital
Phone: 0086-13671921521
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prediction for NAC efficacy; Standardized uptake value(SUV); Target-to-background ratio(TBR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.